Abstract
The paper describes the cases of 3 female health operators with implanted copper IUDs, developing menometrorrhagia some months after an increase of the working time in a Magnetic Resonance Imaging (MRI) Unit (1.5 T), that progressively disappeared when the previous organization, involving discontinuous work shifts at MRI, was re-established. No known factors possibly related to menometrorrhagia were evidenced in the 3 operators, supporting the hypothesis of a role of the exposure to the electromagnetic fields (EMF) induced by the MRI system in symptoms induction. The possible mechanism remains unsettled, but menometrorrhagia might be triggered by a phlogistic stimulus caused by EMF, possibly the low-frequency currents induced in the wires of the IUD during the movements of the operator inside the static magnetic field generated by the MRI permanent magnet. Until now, the problem of possible interactions between copper IUDs and EMF induced by MRI has been considered in patients undergoing imaging, but the possible risk in MRI Units operators has been largely neglected. To our knowledge, the occurrence of menometrorrhagia is not routinely checked in health surveillance of MRI operators, so these symptoms can pass unnoticed, especially if they are transitory. Therefore, underreporting is rather possible. The cases described here support the need for further research on this topic, especially considering the progressive diffusion of more powerful MRI scanners (3 T and more), and of the interventional magnetic resonance imaging, both potentially involving higher EMF exposures, and a large number of MRI female operators, possibly using IUDs. The possibility that MRI operators with implanted metallic IUDs can be included in the group of “workers at particular risk” according to the EU Directive 2004/40/EC should be considered.
Similar content being viewed by others
References
Hess T, Stepanow B, Knopp MV. Safety of intrauterine contraceptive devices during MR imaging. Eur Radiol 1996;6:66–68.
Mühler M, Taupitz M. How safe is magnetic resonance imaging in patients with contraceptive implants? Radiologe 2006;46:574–578.
Mishell DR Jr. Intrauterine Devices: Mechanisms of Action, Safety and Efficacy. Contraception 1998;58:45S–53S.
Pasquale SA, Russer TJ, Foldesy R, Mezrich RS. Lack of interaction between magnetic resonance imaging and the copper-T380A IUD. Contraception 1997;55:169–173.
Shellock FG. Radiofrequency Energy-Induced Heating During MR Procedures: A Review. J Magn Reson Imaging 2000;12:30–36.
Shellock FG. New Metallic Implant Used for Permanent Contraception in Women: Evaluation of MR Safety. Am J Roentgenol 2002;178:1513–1516.
Zieman M, Kanal E. Copper T 380A IUD and magnetic resonance imaging. Contraception 2007;75:93–95.
Mark AS, Hricak H. Intrauterine contraceptive devices MR imaging. Radiology 1987;162:311–314.
ASTM International (American Section of the International Association for Testing Materials). Standard practice for marking medical devices and other items for safety in the magnetic resonance environment. New York: American National Standards Institute; 2005.
Capstick M, McRobbie D, Hand J, Christ A, Kuhn S, Mild KH, et al. An investigation into occupational exposure to electromagnetic fields for personnel working with and around medical magnetic resonance imaging equipment. Report of the Project VT/2007/017. Zurich (CH): Foundation for Research on Information Technology in Society (ITIS); 2008 [cited: 2011 Nov 24]. Available from URL: http://www1.itis.ethz.ch/downloads/VT2007017FinalReportv04.pdf.
Keevil SF, Krestin G. EMF Directive still poses a risk to MRI research in Europe. Lancet 2010;376:1124–1125.
Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 μg versus > 20 μg estrogen combined oral contraceptives for contraception. Cochrane Database Syst 2008;Rev 4:CD003989.
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223–1236.
Pregler JP, DeCherney AH. Women’s Health: Principles and Clinical practice. Hamilton, Ontario: BC Decker Inc.; 2002.
Kulier R, O’Brien P, Helmerhorst FM, Usher-Patel M, d’Arcangues C. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst 2007;Rev 4:CD005347.
EU Directive: Directive 2004/40/EC of the European Parliament and of the Council of 29 April 2004 on the minimum health and safety requirements regarding the exposure of workers to the risks arising from physical agents (electromagnetic fields). Eighteenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC. Off J Eur Union 2004;159:1–26.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Gobba, F., Bianchi, N., Verga, P. et al. Menometrorrhagia in magnetic resonance imaging operators with copper intrauterine contraceptive devices (IUDS): A case report. IJOMEH 25, 97–102 (2012). https://doi.org/10.2478/s13382-012-0005-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s13382-012-0005-y